(Press-News.org) The global burden of sickle cell anemia (SCA), a hereditary blood disorder, is increasing, with almost half a million babies estimated to be born with the condition in 2050, according to a study published in this week's PLOS Medicine. The study, conducted by Frédéric Piel and colleagues from the University of Oxford and Imperial College in the United Kingdom, and the KEMRI/Wellcome Trust Research Programme, Kenya, suggests that implementing basic health interventions could significantly reduce death rates in children aged less than 5 years with the condition. These findings can be used to guide national policy decisions on public health spending.
The researchers used estimated country rates of SCA and information on projected birth rates to show that the number of newborn babies with SCA is likely to increase from roughly 305,800 in 2010 to about 404,200 in 2050. Newborn babies in Nigeria, the Democratic Republic of the Congo, and India will be most affected, accounting for 57% of all of the babies born with SCA in 2010, and this proportion is likely to increase by 2050.
The authors show that implementing basic health interventions for SCA such as newborn screening, penicillin prophylaxis, and vaccination, by 2015, could increase survival of more than five million newborns with SCA by 2050. Similarly, universal screening programs could save the lives of almost 10 million newborns with SCA globally, 85% of whom will be born in sub-Saharan Africa. However, the findings of this study are limited by the uncertainty around these estimates, and the assumptions made by the authors about how the estimated reduced death rates were linked with the health interventions.
The authors say: "Our quantitative approach confirms that the global burden of SCA is increasing, and highlights the need to develop specific national policies for appropriate public health planning, particularly in low- and middle-income countries."
In an accompanying perspective article, David Osrin and Edward Fottrell of UCL Institute of Child Health, United Kingdom (both uninvolved in the study), discuss how as child death rates decrease, the relative burden of child morbidity and disability will increase, saying: "SCA is an inherited disease whose global importance will increase in terms of absolute numbers and relative population burden."
Osrin and Fottrell urge the global health community to respond to the changing patterns of disease burdens, saying: "The estimates from Piel and colleagues underscore the need for both collaborative responses and better data for planning and monitoring."
###
Research Article
Funding: This study was supported by funding from the Wellcome Trust (Biomedical Resources Grant #085406, PI: SIH) and the European Research Council (Advanced Grant - DIVERSITY, PI: SG). SIH is funded by a Senior Research Fellowship from the Wellcome Trust (#095066). TNW is funded by a Senior Clinical Fellowship from the Wellcome Trust (#091758). The funding agencies had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript. This paper is submitted with permission of the Director of KEMRI.
Competing Interests: The authors have declared that no competing interests exist.
Citation: Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN (2013) Global Burden of Sickle Cell Anaemia in Children under Five, 2010: Modelling Based on Demographics, Excess Mortality, and Interventions. PLoS Med 10(7): e1001484. doi:10.1371/journal.pmed.1001484
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001484
Contact:
Frédéric Piel
Senior postdoctoral researcher
University of Oxford
Zoology
Tinbergen Building
South Parks Road
Oxford, OX1 3PS
UNITED KINGDOM
441865271132
fred.piel@zoo.ox.ac.uk
Perspective Article
Funding: EF is supported at Umea° Centre for Global Health Research by FAS, the Swedish Council for Working Life and Social Research. DO is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (091561). The funders played no role in the preparation of the manuscript.
Competing Interests: The authors have no competing interests to declare.
Citation: Fottrell E, Osrin D (2013) Sickle Cell Anaemia in a Changing World. PLoS Med 10(7): e1001483. doi:10.1371/journal.pmed.1001483
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001483
Contact:
David Osrin
Wellcome Trust Fellow and Reader
Institute for Global Health
UCL Institute of Child Health
30 Guilford Street
London, London WC1N 1EH
UNITED KINGDOM
(+44 207) 905 2122
d.osrin@ucl.ac.uk
The global burden of sickle cell anemia in young children is increasing
2013-07-17
ELSE PRESS RELEASES FROM THIS DATE:
Improving systematic reviews of animal studies will help translational medicine
2013-07-17
Many new developments and initiatives have been introduced to improve the quality and translational value of animal research, and must continue with support from the wider scientific community. These are the conclusions of a new article in PLOS Medicine this week by Carlijn Hooijmans and colleagues from the Radboud University Nijmegen Medical Centre, Netherlands, who summarize these new developments.
Focusing on the quality of study conduct, reporting, and replication; systematic reviews and meta-analyses; and study registration, publication bias, and data sharing, the ...
Potential neurological treatments often advance to clinical trials on shaky evidence, study says
2013-07-17
STANFORD, Calif. - Clinical trials of drug treatments for neurological diseases such as Alzheimer's and Parkinson's often fail because the animal studies that preceded them were poorly designed or biased in their interpretation, according to a new study from an international team of researchers. More stringent requirements are needed to assess the significance of animal studies before testing the treatments in human patients, the researchers say.
The team - led by John Ioannidis, MD, DSc, a professor of medicine at the Stanford University School of Medicine and an expert ...
Bias pervades the scientific reporting of animal studies
2013-07-17
A new study published in the open access journal PLOS Biology suggests that the scientific literature could be compromised by substantial bias in the reporting of animal studies, and may be giving a misleading picture of the chances that potential treatments could work in humans.
Testing a new therapeutic intervention (such as a drug or surgical procedure) on human subjects is expensive, risky and ethically complex, so the vast majority are first tested on animals. Unfortunately, cost and ethical issues constrain the size of animal studies, giving them limited statistical ...
6 steps could cut heart failure readmissions
2013-07-17
There are six procedural things hospital teams can do to help heart failure patients avoid another hospital stay in the 30 days after they're discharged — and if all six are followed, patients are even more likely to avoid readmission, according to new research in the American Heart Association's journal Circulation: Cardiovascular Quality and Outcomes.
Each step alone had some impact, but researchers discovered that if all six recommendations are followed, readmissions could drop as much as 2 percent. The study's lead author said that may seem like a small number, but ...
Longer duration of obesity associated with subclinical coronary heart disease
2013-07-17
In a study of adults recruited and followed up over the past 3 decades in the United States, longer duration of overall and abdominal obesity beginning in young adulthood was associated with higher rates of coronary artery calcification, a subclinical predictor of coronary heart disease, according to a study in the July 17 issue of JAMA.
"Subclinical atherosclerosis, identified by the presence of coronary artery calcification (CAC), progresses over time, and predicts the development of coronary heart disease events," according to background information in the article. ...
Study examines characteristics, features of West Nile virus outbreaks
2013-07-17
An analysis of West Nile virus epidemics in Dallas County in 2012 and previous years finds that the epidemics begin early, after unusually warm winters; are often in similar geographical locations; and are predicted by the mosquito vector index (an estimate of the average number of West Nile virus-infected mosquitoes collected per trap-night), information that may help prevent future outbreaks of West Nile virus-associated illness, according to a study in the July 17 issue of JAMA.
"After declining over the prior 5 years, mosquito-borne West Nile virus infection resurged ...
Review article describes epidemiology, characteristics and prevention of West Nile virus
2013-07-17
Lyle R. Petersen, M.D., M.P.H., of the Centers for Disease Control and Prevention, U.S. Public Health Service, Department of Health and Human Services, Fort Collins, Colo., and colleagues conducted a review of the medical literature and national surveillance data to examine the ecology, virology, epidemiology, clinical characteristics, diagnosis, prevention, and control of West Nile virus.
"West Nile virus has become endemic in all 48 contiguous United States as well as all Canadian provinces since its discovery in North America in New York City in 1999. It has produced ...
Combination therapy may help improve rate of favorable neurological status following cardiac arrest
2013-07-17
Among patients who experienced in-hospital cardiac arrest requiring vasopressors (drugs that increase blood pressure), use of a combination therapy during cardiopulmonary resuscitation resulted in improved survival to hospital discharge with favorable neurological status, according to a study in the July 17 issue of JAMA.
"Neurological outcome after cardiac arrest has been the main end point of several randomized clinical trials (RCTs). Neurologically favorable survival differs from overall survival. Among cardiac arrest survivors, the prevalence of severe cerebral ...
Use of ADT for treatment of prostate cancer linked with increased risk of kidney injury
2013-07-17
In a study that included more than 10,000 men with nonmetastatic prostate cancer, use of androgen deprivation therapy (ADT) was associated with a significantly increased risk of acute kidney injury, with variations observed with certain types of ADTs, according to a study in the July 17 issue of JAMA.
"Androgen deprivation therapy is the mainstay treatment for patients with advanced prostate cancer. While this therapy has been traditionally reserved for patients with advanced disease, ADT is increasingly being used in patients with less severe forms of the cancer, such ...
Nursing home residents with advanced cognitive impairment who undergo multiple hospitalizations
2013-07-17
"Multiple hospitalizations for complications from a terminal illness may be burdensome for elderly patients and reflect poor quality care," write Joan M. Teno, M.D., M.S., of the Warren Alpert School of Medicine of Brown University, Providence, R.I., and colleagues, who conducted a study to examine whether the occurrence of multiple hospitalizations for the complications of infections or dehydration was associated with survival.
As reported in a Research Letter, the study population was identified using data from the national Minimum Data Set repository, which includes ...